• About Us
  • Paper Locations
  • Contact
Hispanic News || Shirley Ann Flower Shop || RS Deer Ranch
March 24, 2023
MEDIA KIT
African American News and Issues
63 °f
Houston
  • National
  • Local
  • Opinion
  • Sports
  • Education
  • Health
  • Politics
  • Announcements
  • Afram TV
  • Events
  • Entertainment
No Result
View All Result
African American News and Issues
  • National
  • Local
  • Opinion
  • Sports
  • Education
  • Health
  • Politics
  • Announcements
  • Afram TV
  • Events
  • Entertainment
No Result
View All Result
African American News and Issues
No Result
View All Result
  • AframNews Media Kit
  • About
  • Paper Locations
Home COVID-19

Moderna vaccine appears to offer strongest protection against COVID

aframnews by aframnews
September 18, 2021
in COVID-19, Health, News, NNPA Coronavirus Task Force
0
Moderna vaccine appears to offer strongest protection against COVID
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
FacebookTwitterPinterestLinkedIn

According to a new report from the Centers for Disease Control and Prevention, two-dose regimens of the Moderna and Pfizer-BioNTech mRNA vaccines provided a high level of protection against COVID-19 hospitalizations in a real-world evaluation at 21 U.S. hospitals during the period between March 11 and August 15.

You might also like

Obamacare During 2022

Breast Cancer Survivor Latonya Payne

Mental Statistics In America

Vaccine effectiveness against COVID-19 hospitalization for Moderna and Pfizer-BioNTech doses were 93 percent and 88 percent, respectively, whereas the single-dose Janssen [Johnson & Johnson] vaccine had a lower effectiveness rate at 71 percent.

Protection for the Pfizer-BioNTech vaccine declined four months after vaccination.

Released Friday, September 17, the report revealed that individuals vaccinated with the Janssen vaccine also had lower post-vaccination anti-SARS-CoV-2 antibody levels than did recipients of mRNA vaccines.
In addition, although an immunologic correlate of protection has not been established for COVID-19 vaccines, the researchers found that antibody titers after infection and vaccination have been associated with protection.

“These real-world data suggest that the 2-dose Moderna and Pfizer-BioNTech mRNA vaccine regimens provide more protection than does the 1-dose Janssen viral vector vaccine regimen,” the researchers wrote.

“Although the Janssen vaccine had lower observed vaccine effectiveness, one dose of Janssen vaccine still reduced risk for COVID-19–associated hospitalization by 71 percent.”
The study included 3,689 patients.

Overall, 2,362 (64 percent) were unvaccinated; 476 (12.9 percent) were fully vaccinated with the Moderna vaccine; 738 (20 percent) were fully vaccinated with the Pfizer-BioNTech vaccine, and 113 (3.1 percent) were fully vaccinated with the Janssen vaccine.

Among all participants, the median age was 58 years, 48 percent female, 23 percent non-Hispanic Black, and 18 percent Hispanic.

Efficacy for the Moderna vaccine was 93 percent at 14 to 120 days (the median equaled 66 days) after receiving the second vaccine dose and 92 percent after 120 days (with the median equaling 141 days).
For Pfizer-BioNTech, efficacy stood at 91 percent at 14 to 120 days (the median equaled 69 days) after receiving the second vaccine dose but declined significantly to 77 percent at more than 120 days (the median equaled 143 days).

The postvaccination antibody analysis included 100 healthy volunteers, 32 fully vaccinated with Moderna, 51 fully vaccinated with Pfizer-BioNTech, and 17 with Janssen.

Antibody levels were higher in participants vaccinated with the Moderna vaccine than those who received the Pfizer-BioNTech vaccine or the Janssen vaccine.

The report revealed that anti-spike levels in participants vaccinated with the Moderna vaccine did not significantly differ from those in recipients of the Pfizer-BioNTech but were considerably higher than levels in participants who received the Janssen.

The report arrives as a U.S. Food and Drug Administration panel reviewed the need for booster shots of the Pfizer-BioNTech coronavirus vaccine.

The panel also expected to vote on whether the agency should approve additional doses for people 16 and older.

“We will evaluate and see,” said Dr. James Hildreth, the president and CEO of Meharry Medical College and an FDA panelist deciding on the booster shots.

Tags: antibody levelsBioNTechCOVID-19effectivenessFDAhospitalizationsJannsenJohnson & Johnsonmeharry medical collegeModernaPfizerReportSARS-CoV-2 vaccines
Share30Tweet19
aframnews

aframnews

Recommended For You

Obamacare During 2022

by NNPA
December 31, 2022
0
Obamacare During 2022

President Joe Biden said he promised to lower costs for families and ensure that all Americans have access to quality affordable health care. On Tuesday, Dec. 27, the...

Read more

Breast Cancer Survivor Latonya Payne

by Keneth Payne
October 22, 2022
0
Breast Cancer Survivor Latonya Payne

Did you know that Breast Cancer is one of the top cancers that makes up majority of the population of deaths worldwide? In honor of Breast Cancer Awareness...

Read more

Mental Statistics In America

by aframnews
October 18, 2022
0
Mental Statistics In America

The District of Columbia counts among the top 10 states with the best mental health, or the combination of the lowest prevalence of mental illness and greater access...

Read more

The Pink Fight

by NNPA
October 15, 2022
0
The Pink Fight

This year, the American Cancer Society (ACS) estimates that health professionals will diagnose more than 287,850 new cases of invasive breast cancer and 51,400 new cases of ductal carcinoma...

Read more

Breast Cancer Awareness

by Chelsea Davis-Bibb, Ed.D.
October 8, 2022
0
Breast Cancer Awareness

October has been designated for Breast Cancer Awareness Month. There are many women all over the world who are currently battling Breast Cancer. According to the National Breast...

Read more
Next Post
Rep. Beatty introduces legislation to establish National Rosa Parks Day

Rep. Beatty introduces legislation to establish National Rosa Parks Day

Latest Articles

Commissioner Rodney Ellis’ Statement on former Houston City Council Member Ada Edward’s Death

Commissioner Rodney Ellis’ Statement on former Houston City Council Member Ada Edward’s Death

March 23, 2023
Booker T Washington – Eagles Varsity Basketball Report

Booker T Washington – Eagles Varsity Basketball Report

March 23, 2023
Wonder Woman Conference Returns May 10-13, 2023

Wonder Woman Conference Returns May 10-13, 2023

March 22, 2023

NEED PAST ISSUES?

Search our archive of past issues Receive our Latest Updates
* indicates required
  • Local
  • National
  • Community
  • Education
  • Politics
  • COVID-19
  • Entertainment
  • Lifestyle
  • Sports

ARTICLES

  • Local
  • National
  • Community
  • Education
  • Politics
  • COVID-19
  • Entertainment
  • Lifestyle
  • Sports

CONNECT WITH US

  • Home
  • Advertise With Us
  • Contact

OTHER PUBLICATIONS

  • Hispanic News
  • Shirley Ann’s Flower Shop
African American News and Issues

African American News & Issues
6130 Wheatley St
Houston, TX 77091
(713) 692-1892

Subscribe To Our Newsletter

Copyright © 2023. African American News & Issues. All rights reserved. Private Policy | Terms of Use |

No Result
View All Result
  • Home
  • National
  • Local
  • Opinion
  • Sports
  • Education
  • Health
  • Politics
  • Entertainment
  • Announcements
  • Events
  • Afram TV
  • Contact

Copyright © 2023. African American News & Issues. All rights reserved. Private Policy | Terms of Use |

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?